ELEDON PHARMACEUTICALS INC's ticker is ELDN and the CUSIP is 28617K101. A total of 31 filers reported holding ELEDON PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.24 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $17,850 | -41.9% | 13,029 | 0.0% | 0.00% | -100.0% |
| Q1 2023 | $30,748 | -76.3% | 13,029 | -60.6% | 0.00% | -50.0% |
| Q1 2022 | $130,000 | -11.0% | 33,092 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $146,000 | -28.8% | 33,092 | 0.0% | 0.00% | -33.3% |
| Q3 2021 | $205,000 | -21.8% | 33,092 | 0.0% | 0.00% | -25.0% |
| Q2 2021 | $262,000 | – | 33,092 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 234,803 | $321,680 | 0.34% |
| BVF INC/IL | 4,326,710 | $5,927,593 | 0.16% |
| ARMISTICE CAPITAL, LLC | 1,824,000 | $2,498,880 | 0.04% |
| SVB FINANCIAL GROUP | 13,472 | $18,457 | 0.04% |
| JMAC ENTERPRISES LLC | 58,041 | $79,516 | 0.02% |
| Woodline Partners LP | 603,993 | $827,470 | 0.01% |
| INGALLS & SNYDER LLC | 51,849 | $71 | 0.00% |
| Ensign Peak Advisors, Inc | 443,001 | $606,911 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 27,150 | $37,196 | 0.00% |
| Curi RMB Capital, LLC | 10,000 | $13,700 | 0.00% |